Bayer

The Bayer GroupBayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed 118,900 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion.

www.bayer.com.

Bayer RSS Channel

Display # 
Title Published Date
Bayer off to a successful start in 2016 26 April 2016
2016 Otto Bayer Award goes to Professor Dr. Dirk Trauner 25 April 2016
Bayer continues to grow its open innovation activities 09 February 2016
Bayer halves the price of its contraceptive implant Jadelle® for women in developing countries 08 January 2016
Bayer and CRISPR Therapeutics AG join forces to discover, develop and commercialize potential cures for serious genetic diseases 21 December 2015
Bayer's new five-year-contraceptive submitted for EU and US marketing authorization 20 November 2015
Bayer aligns organization with Life Science businesses 18 September 2015
New scholarships worth EUR 332,000 awarded by Bayer Foundation to promote international talents 16 September 2015
Bayer significantly improves earnings 29 July 2015
Bayer to divest Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd. for EUR 1,022 million 10 June 2015
Xarelto® approved in China across three indications in the area of venous and arterial thromboembolism 07 May 2015
Strong start to the year for Bayer 30 April 2015
Bayer aspires to significantly expand Life Science businesses 11 March 2015
Bayer forms collaboration with academic and governmental institutions for Rivaroxaban study 10 February 2015
Bayer operationally strong - strategic focus on Life Science businesses 02 November 2014
Bayer supports World Thrombosis Day as founding global partner 13 October 2014
Bayer closes acquisition of consumer care business of Merck & Co., Inc., United States, for USD 14.2 billion 01 October 2014
Safety and sustained benefits of Adempas® from Bayer confirmed by results of long-term studies 08 September 2014
Bayer continues positive business development 30 July 2014
Bayer and Orion Corporation to develop and commercialize novel prostate cancer treatment 02 June 2014

Most Popular Now

AstraZeneca and Eli Lilly and Compa…

AstraZeneca and Eli Lilly and Company today announced that AMARANTH, a Phase II/III study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in...

Read more

NIH launches large clinical trials …

Enrollment has begun in the first of two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV infection. Known as the A...

Read more

Vitamin D improves heart function, …

A daily dose of vitamin D3 improves heart function in people with chronic heart failure, a five-year University of Leeds research project has found. Dr Klaus Witte, from ...

Read more

Pfizer announces termination of pro…

Pfizer Inc. (NYSE: PFE) announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies. The deci...

Read more

New analysis shows only minority of…

Boehringer Ingelheim has announced a new publication showing that levels of white blood cells called eosinophils can help identify patients with COPD who may and may not ...

Read more

Researchers open the way to new tre…

In a recent paper published in Nature Communications, a group of Case Western University School of Medicine researchers presented their discovery of the full-length struc...

Read more

Implantable device targets pancreat…

Pancreatic cancer is the third leading cause of cancer deaths in the United States, in part because it is very difficult for chemotherapy drugs to reach the pancreas, whi...

Read more

Physicians' knowledge about FDA app…

Since 2012, the FDA can designate a drug as a "breakthrough therapy" if preliminary clinical evidence - such as an improvement in a pharmacodynamic biomarker - suggests a...

Read more

Global spending on health is expect…

Global inequities in health spending are expected to persist and intensify over the next 25 years, according to a new study that estimates total health financing in count...

Read more

Americans live longer but with disa…

Americans are living longer but in poorer health, according to a new study. The USC-led study examined life expectancy trends and disability rates in a 40-year period, fr...

Read more

FDA grants priority review for Roch…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) and granted P...

Read more

Nanoparticles show promise for trea…

Nanoparticles designed to block a cell-surface molecule that plays a key role in inflammation could be a safe treatment for inflammatory bowel disease (IBD), according to...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest World Pharma Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]